Sands Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-874,765
| Closed | -$121M | – | 68 |
|
|
2023
Q1 | $121M | Sell |
874,765
-1,276,613
| -59% | -$176M | 0.4% | 49 |
|
|
2022
Q4 | $279M | Sell |
2,151,378
-330,997
| -13% | -$42.9M | 1.05% | 30 |
|
|
2022
Q3 | $274M | Sell |
2,482,375
-1,228,726
| -33% | -$136M | 1.03% | 33 |
|
|
2022
Q2 | $278M | Sell |
3,711,101
-1,071,850
| -22% | -$80.3M | 0.96% | 32 |
|
|
2022
Q1 | $374M | Sell |
4,782,951
-581,676
| -11% | -$45.4M | 0.86% | 35 |
|
|
2021
Q4 | $483M | Sell |
5,364,627
-201,476
| -4% | -$18.1M | 0.9% | 35 |
|
|
2021
Q3 | $515M | Sell |
5,566,103
-41,045
| -0.7% | -$3.8M | 0.86% | 35 |
|
|
2021
Q2 | $436M | Buy |
5,607,148
+2,579,058
| +85% | +$200M | 0.74% | 38 |
|
|
2021
Q1 | $226M | Buy |
3,028,090
+2,050,954
| +210% | +$153M | 0.44% | 49 |
|
|
2020
Q4 | $167M | Sell |
977,136
-888,327
| -48% | -$151M | 0.32% | 50 |
|
|
2020
Q3 | $262M | Sell |
1,865,463
-2,473,793
| -57% | -$347M | 0.57% | 45 |
|
|
2020
Q2 | $696M | Sell |
4,339,256
-63,675
| -1% | -$10.2M | 1.68% | 23 |
|
|
2020
Q1 | $431M | Sell |
4,402,931
-154,568
| -3% | -$15.1M | 1.44% | 25 |
|
|
2019
Q4 | $588M | Buy |
4,557,499
+605,409
| +15% | +$78.1M | 1.71% | 23 |
|
|
2019
Q3 | $298M | Buy |
3,952,090
+426,514
| +12% | +$32.1M | 0.96% | 32 |
|
|
2019
Q2 | $536M | Sell |
3,525,576
-91,518
| -3% | -$13.9M | 1.59% | 22 |
|
|
2019
Q1 | $431M | Buy |
3,617,094
+522,327
| +17% | +$62.3M | 1.33% | 24 |
|
|
2018
Q4 | $338M | Buy |
3,094,767
+1,193,203
| +63% | +$130M | 1.21% | 26 |
|
|
2018
Q3 | $307M | Buy |
+1,901,564
| New | +$307M | 0.87% | 33 |
|